TAIJA MOSES: Open Payments
NPI 1982893905 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,693 in 69 payments from 19 companies in 2025. Trend: 2023 $1,020 · 2024 $1,843 · 2025 $1,693
Food & beverage: $1,693
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $300 |
| Janssen Biotech, Inc. | 9 | $296 |
| UCB, Inc. | 8 | $272 |
| ABBVIE INC. | 15 | $221 |
| Organon LLC | 4 | $105 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Lilly USA, LLC | 4 | $74 |
| GENZYME CORPORATION | 2 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $39 |
Products named: DUPIXENT, TREMFYA, Bimzelx, RINVOQ, SKYRIZI, COSENTYX, VTAMA, SPEVIGO.
Industry payments across PA — which companies pay providers there.
